Roberto Pisoni is a Nephrology physician affiliated with Medical University of South Carolina. OpenAlex indexes 61 publications with 2,394 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
171 Ashley Ave
Charleston, SC 294250100
Telephone
843-792-1414Provider last certified this registry record 22 Oct 2020.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mallinckrodt Hospital Products Inc.Program year20251 payment
- Calliditas Therapeutics US Inc.Program year20251 payment
- Travere Therapeutics, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.6%Loop diuretic12.7%Torsemide57%Furosemide43%Part D<11 patientsCalcium channel blocker12.5%Amlodipine Besylate62%Nifedipine Er39%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
16.8%SGLT2 inhibitor7.5%Farxiga61%Jardiance39%Part D<11 patientsProton pump inhibitor3.6%Pantoprazole Sodium100%Part D<11 patients+ 2 more classes in this area
Musculoskeletal
4.6%Xanthine oxidase inhibitor4.6%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Annals of Internal Medicine
2023 - Old Friend in Camouflage: Polyarteritis Nodosa With Thrombotic Microangiopathy
Journal of the American Society of Nephrology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Tanya Turan, MD
Medical University of South Carolina
Michael Zile, MD
Medical University of South Carolina
Don Rockey, MD
Medical University of South Carolina
William Creasman, MD
Medical University of South Carolina
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”